Background: The uptake of a COVID-19 vaccine among children will be instrumental in limiting the spread of the disease. Some vaccine candidates have gained fast-track status for regulatory approval, with the first Phase 3 trials beginning in July 2020.
Purpose: To investigate predictors associated with global caregivers’ willingness to accept an accelerated regulatory process and intent to vaccinate their children during the COVID-19 pandemic.
Methods: An international cross-sectional survey or caregivers arriving with their children to 16 pediatric Emergency Departments (ED) across six countries from March 26 to May 31, 2020.
Results: Less than half (43%) of caregivers reported that they are willing to accept less rigorous testing and approval for a new COVID-19 vaccine. Almost two-thirds (65%) of caregivers reported that they intent to vaccinate their child against COVID-19, once a vaccine is available. We identified child and caregiver factors as associated predictors and qualitatively evaluated commonly reported reasons for acceptance and refusal.
Conclusions: The majority of caregivers intend to vaccinate their children against COVID-19 and uptake will likely be associated with specific factors such as child and caregiver demographics and vaccination history. Public health strategies need to address barriers to uptake by providing evidence about an upcoming COVID-19 vaccine’s safety and efficacy, highlighting the risks and consequences of infection in children, and educating caregivers on the role of vaccination.